Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
September 18th Event in New York City to Include a Review of the Opportunity for Investigational Therapy IMNN-001 (IL-12) to Tr...
HC Wainwright & Co. analyst Emily Bodnar reiterates Imunon (NASDAQ:IMNN) with a Buy and maintains $14 price target.
Imunon (NASDAQ:IMNN) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.60) by 15 ...
HC Wainwright & Co. analyst Emily Bodnar maintains Imunon (NASDAQ:IMNN) with a Buy and raises the price target from $12 ...
Imunon shares are trading lower by 61% during Wednesday's session. The company announced a $10 million registered direct of...
